Cancer-Cell-Intrinsic cGAS Expression Mediates Tumor Immunogenicity.
暂无分享,去创建一个
M. van den Broek | K. Silina | W. Barchet | Linda Schadt | H. Yagita | Giulia Lucchiari | Virginia Cecconi | Colin Sparano | Nicole Angelika Schweiger | E. Guggisberg | Sascha Saba | Zuzana Nascakova
[1] Zhijian J. Chen,et al. cGAS in action: Expanding roles in immunity and inflammation , 2019, Science.
[2] J. Bertin,et al. Design of amidobenzimidazole STING receptor agonists with systemic activity , 2018, Nature.
[3] R. Vance,et al. Tumor‐Derived cGAMP Triggers a STING‐Mediated Interferon Response in Non‐tumor Cells to Activate the NK Cell Response , 2018, Immunity.
[4] L. Galluzzi,et al. Cytosolic DNA Sensing in Organismal Tumor Control. , 2018, Cancer Cell.
[5] G. Freeman,et al. LSD1 Ablation Stimulates Anti-tumor Immunity and Enables Checkpoint Blockade , 2018, Cell.
[6] G. Barber,et al. Extrinsic Phagocyte-Dependent STING Signaling Dictates the Immunogenicity of Dying Cells. , 2018, Cancer cell.
[7] Zhijian J. Chen,et al. The cGAS–cGAMP–STING pathway connects DNA damage to inflammation, senescence, and cancer , 2018, The Journal of experimental medicine.
[8] M. Fehlings,et al. Bystander CD8+ T cells are abundant and phenotypically distinct in human tumour infiltrates , 2018, Nature.
[9] R. Weinberg,et al. Understanding the tumor immune microenvironment (TIME) for effective therapy , 2018, Nature Medicine.
[10] Samuel F. Bakhoum,et al. Chromosomal instability drives metastasis through a cytosolic DNA response , 2017, Nature.
[11] C. Figdor,et al. Migrating into the Tumor: a Roadmap for T Cells. , 2017, Trends in cancer.
[12] J. Lunceford,et al. IFN-&ggr;–related mRNA profile predicts clinical response to PD-1 blockade , 2017, The Journal of clinical investigation.
[13] Martin A. M. Reijns,et al. cGAS surveillance of micronuclei links genome instability to innate immunity , 2017, Nature.
[14] C. Ager,et al. Intratumoral STING Activation with T-cell Checkpoint Modulation Generates Systemic Antitumor Immunity , 2017, Cancer Immunology Research.
[15] Dennis E Discher,et al. Mitotic progression following DNA damage enables pattern recognition within micronuclei , 2017, Nature.
[16] C. N. Coleman,et al. DNA exonuclease Trex1 regulates radiotherapy-induced tumour immunogenicity , 2017, Nature Communications.
[17] J. Wolchok,et al. Intratumoral delivery of inactivated modified vaccinia virus Ankara (iMVA) induces systemic antitumor immunity via STING and Batf3-dependent dendritic cells , 2017, Science Immunology.
[18] Yuanyuan Ruan,et al. Decreased expression of STING predicts poor prognosis in patients with gastric cancer , 2017, Scientific Reports.
[19] Zhijian J. Chen,et al. cGAS is essential for the antitumor effect of immune checkpoint blockade , 2017, Proceedings of the National Academy of Sciences.
[20] I. Mellman,et al. Elements of cancer immunity and the cancer–immune set point , 2017, Nature.
[21] K. Ishii,et al. DNA-Containing Exosomes Derived from Cancer Cells Treated with Topotecan Activate a STING-Dependent Pathway and Reinforce Antitumor Immunity , 2017, The Journal of Immunology.
[22] Hsi-Yuan Huang,et al. DNA-Sensing and Nuclease Gene Expressions as Markers for Colorectal Cancer Progression , 2016, Oncology.
[23] L. Zitvogel,et al. Immunogenic cell death in cancer and infectious disease , 2016, Nature Reviews Immunology.
[24] J. Massagué,et al. Carcinoma-astrocyte gap junctions promote brain metastasis by cGAMP transfer , 2016, Nature.
[25] D. Munn,et al. STING Promotes the Growth of Tumors Characterized by Low Antigenicity via IDO Activation. , 2016, Cancer research.
[26] Xiangshi Tan,et al. Antitumor Activity of cGAMP via Stimulation of cGAS-cGAMP-STING-IRF3 Mediated Innate Immune Response , 2016, Scientific Reports.
[27] G. Barber,et al. Deregulation of STING Signaling in Colorectal Carcinoma Constrains DNA Damage Responses and Correlates With Tumorigenesis. , 2016, Cell reports.
[28] S. Gabriel,et al. Genomic correlates of response to CTLA-4 blockade in metastatic melanoma , 2015, Science.
[29] George E. Katibah,et al. Direct Activation of STING in the Tumor Microenvironment Leads to Potent and Systemic Tumor Regression and Immunity. , 2015, Cell reports.
[30] M. Okoniewski,et al. Complement is a central mediator of radiotherapy-induced tumor-specific immunity and clinical response. , 2015, Immunity.
[31] K. Ishii,et al. Genome-derived cytosolic DNA mediates type I interferon-dependent rejection of B cell lymphoma cells. , 2015, Cell reports.
[32] A. Kröger,et al. DNA damage primes the type I interferon system via the cytosolic DNA sensor STING to promote anti-microbial innate immunity. , 2015, Immunity.
[33] E. Janssen,et al. STING-Mediated DNA Sensing Promotes Antitumor and Autoimmune Responses to Dying Cells , 2014, The Journal of Immunology.
[34] Ying Wang,et al. STING-dependent cytosolic DNA sensing mediates innate immune recognition of immunogenic tumors. , 2014, Immunity.
[35] R. Weichselbaum,et al. STING-Dependent Cytosolic DNA Sensing Promotes Radiation-Induced Type I Interferon-Dependent Antitumor Immunity in Immunogenic Tumors. , 2014, Immunity.
[36] Sebastian Amigorena,et al. Dissecting the tumor myeloid compartment reveals rare activating antigen-presenting cells critical for T cell immunity. , 2014, Cancer cell.
[37] M. Delorenzi,et al. Cancer cell–autonomous contribution of type I interferon signaling to the efficacy of chemotherapy , 2014, Nature Medicine.
[38] G. Barber,et al. Inflammation-driven carcinogenesis is mediated through STING , 2014, Nature Communications.
[39] Jonathan L. Schmid-Burgk,et al. Cell intrinsic immunity spreads to bystander cells via the intercellular transfer of cGAMP , 2013, Nature.
[40] H. Schreiber,et al. Innate and adaptive immune cells in the tumor microenvironment , 2013, Nature Immunology.
[41] V. Hornung,et al. cGAS produces a 2′-5′-linked cyclic dinucleotide second messenger that activates STING , 2013, Nature.
[42] Roger A. Jones,et al. Cyclic [G(2′,5′)pA(3′,5′)p] Is the Metazoan Second Messenger Produced by DNA-Activated Cyclic GMP-AMP Synthase , 2013, Cell.
[43] Zhijian J. Chen,et al. Cyclic GMP-AMP Is an Endogenous Second Messenger in Innate Immune Signaling by Cytosolic DNA , 2013, Science.
[44] Zhijian J. Chen,et al. Cyclic GMP-AMP Synthase Is a Cytosolic DNA Sensor That Activates the Type I Interferon Pathway , 2013, Science.
[45] M. van den Broek,et al. Radiotherapy Promotes Tumor-Specific Effector CD8+ T Cells via Dendritic Cell Activation , 2012, The Journal of Immunology.
[46] R. Schreiber,et al. Type I interferon is selectively required by dendritic cells for immune rejection of tumors , 2011, The Journal of experimental medicine.
[47] K. Murphy,et al. Host type I IFN signals are required for antitumor CD8+ T cell responses through CD8α+ dendritic cells , 2011, The Journal of experimental medicine.
[48] R. Weichselbaum,et al. The efficacy of radiotherapy relies upon induction of type i interferon-dependent innate and adaptive immunity. , 2011, Cancer research.
[49] M. Faretta,et al. Bacteria-Induced Gap Junctions in Tumors Favor Antigen Cross-Presentation and Antitumor Immunity , 2010, Science Translational Medicine.
[50] G. Barber,et al. STING regulates intracellular DNA-mediated, type I interferon-dependent innate immunity , 2009, Nature.
[51] K. Rajewsky,et al. Novel Reporter Mouse Reveals Constitutive and Inflammatory Expression of IFN-β In Vivo1 , 2009, The Journal of Immunology.
[52] R. Locksley,et al. Visualization of IFNβ production by plasmacytoid versus conventional dendritic cells under specific stimulation conditions in vivo , 2008, Proceedings of the National Academy of Sciences.
[53] G. Barber,et al. STING an Endoplasmic Reticulum Adaptor that Facilitates Innate Immune Signaling , 2008, Nature.
[54] R. Schreiber,et al. Type I IFN Contributes to NK Cell Homeostasis, Activation, and Antitumor Function1 , 2007, The Journal of Immunology.
[55] Robert D. Schreiber,et al. Interferons, immunity and cancer immunoediting , 2006, Nature Reviews Immunology.
[56] Z. Trajanoski,et al. Type, Density, and Location of Immune Cells Within Human Colorectal Tumors Predict Clinical Outcome , 2006, Science.
[57] E. Jaffee,et al. The immunodominant major histocompatibility complex class I-restricted antigen of a murine colon tumor derives from an endogenous retroviral gene product. , 1996, Proceedings of the National Academy of Sciences of the United States of America.
[58] G. Lutfalla,et al. Domains of interaction between alpha interferon and its receptor components. , 1994, Journal of molecular biology.
[59] R. Steinman,et al. Generation of large numbers of dendritic cells from mouse bone marrow cultures supplemented with granulocyte/macrophage colony-stimulating factor , 1992, The Journal of experimental medicine.
[60] Holger Moch,et al. Germinal Centers Determine the Prognostic Relevance of Tertiary Lymphoid Structures and Are Impaired by Corticosteroids in Lung Squamous Cell Carcinoma. , 2018, Cancer research.
[61] M. van den Broek,et al. A Quantitative Pathology Approach to Analyze the Development of Human Cancer-Associated Tertiary Lymphoid Structures. , 2018, Methods in molecular biology.
[62] Shelly A Bambina,et al. Radiotherapy Combined with Novel STING-Targeting Oligonucleotides Results in Regression of Established Tumors. , 2016, Cancer research.
[63] M. Fenech,et al. Molecular mechanisms of micronucleus, nucleoplasmic bridge and nuclear bud formation in mammalian and human cells. , 2011, Mutagenesis.
[64] J. Haveman,et al. Clonogenic assay of cells in vitro , 2006, Nature Protocols.
[65] R. Medzhitov,et al. Recognition of cytosolic DNA activates an IRF3-dependent innate immune response. , 2006, Immunity.
[66] C. Biron,et al. Natural killer cells in antiviral defense: function and regulation by innate cytokines. , 1999, Annual review of immunology.